Publications by authors named "Bien Matawaran"

Claim this Profile
P
Predictors of Poor Glycemic Control and Increased Glucose Variability Among Admitted Moderate to Critical COVID-19 Patients with Type 2 Diabetes Mellitus: A Single Center Cross-sectional Study.
John Paul Martin Bagos, Mendoza Erick, Bien Matawaran

J ASEAN Fed Endocr Soc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations for the use of SGLT-2 inhibitors in the Asia-Pacific countries-An expert consensus statement.
Adrian Liew, Aida Lydia, Bien J Matawaran, Paweena Susantitaphong, Huong Thi Bich Tran

Nephrology (Carlton)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Recommendations for the use of Neurotropic B vitamins (B1, B6, and B12) for the Management of Peripheral Neuropathy: Consensus from a Multidisciplinary Expert Panel.
Rizaldy T Pinzon, Natalie Schellack, Bien J Matawaran, Man W Tsang, Chaicharn Deerochanawong

J Assoc Physicians India· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the Journey of Patients with Painful Diabetic Peripheral Neuropathy in the Philippines.
Rosalina B Espiritu-Picar, Bien J Matawaran, Jermaine M Lim, Priyan Ratnasingham

Acta Med Philipp· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
Chin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, Bien Matawaran, Wayne Huey-Herng Sheu

Diabetes Obes Metab· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E Cooper, Bien J Matawaran

Eur Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations.
Wayne Huey Herng Sheu, Siew Pheng Chan, Bien J Matawaran, Chaicharn Deerochanawong, Ambrish Mithal

Diabetes Metab J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
Chaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, Wayne H-H Sheu, Juliana Chan

Diabetes Obes Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).
Sanjay Kalra, Stephen Atkin, Antonio Cervera, Ashok Kumar Das, Ozgur Demir, Bien J Matawaran

Adv Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).
Sanjay Kalra, Stephen Atkin, Antonio Cervera, Ashok Kumar Das, Ozgur Demir, Bien J Matawaran

Adv Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East.
Mostafa Alshamiri, Mahmood Mohammed Ali Ghanaim, Philip Barter, Kuan-Cheng Chang, Jian-Jun Li, Bien J Matawaran

Int J Gen Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
Apichati Vichayanrat, Bien J Matawaran, Aris Wibudi, Hossain S Ferdous, Azizul Hasan Aamir

J Diabetes· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis